Guided Therapeutics (GTHP) Other Non Operating Income (2013 - 2026)
Guided Therapeutics' (GTHP) quarterly Other Non Operating Income came in at -$127000.0 in Q2 2026, down 164.58% year-over-year from $196645.2 in Q2 2025, and up 35.86% quarter-over-quarter from -$198000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Other Non Operating Income (2013 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Other Non Operating Income across 14 years of filings, most recently posting -$127000.0 for Q2 2026.
- In Q2 2026, Other Non Operating Income fell 164.58% year-over-year to -$127000.0; the TTM figure through Jun 2026 stood at -$1.1 million (down 426.57% YoY), while the FY2025 annual figure was -$824000.0, down 166.67% from the prior year.
- Other Non Operating Income came in at -$127000.0 for Q2 2026 at Guided Therapeutics, up from -$198000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $52000.0 in Q1 2025 to a low of -$508000.0 in Q4 2025.
- Average Other Non Operating Income over 5 years is -$72555.6, with a median of -$14500.0 recorded in 2023.
- Year-over-year, Other Non Operating Income plunged 647.06% in 2024 and surged 5100.0% in 2025.
- Over 5 years, Other Non Operating Income stood at $14000.0 in 2022, then tumbled by 314.29% to -$30000.0 in 2023, then plunged by 293.33% to -$118000.0 in 2024, then tumbled by 330.51% to -$508000.0 in 2025, then surged by 75.0% to -$127000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$127000.0 in Q2 2026, -$198000.0 in Q1 2026, and -$508000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -127,000.00 |
| Mar 31, 2026 | -198,000.00 |
| Dec 31, 2025 | -508,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | -64,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Sep 30, 2021 | 763,000.00 |